欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号CZ/H/0802/001
药品名称Octreotide LAI Teva B.V.
活性成分
    • Octreotide acetate 10.0 mg
剂型Powder and solvent for suspension for injection
上市许可持有人Teva B.V. Swensweg 5, Haarlem 2031GA Netherlands
参考成员国 - 产品名称Czechia (CZ)
OCTREOTIDE TEVA B. V.
互认成员国 - 产品名称
    • Germany (DE)
许可日期2019/04/16
最近更新日期2025/07/18
药物ATC编码
    • H01CB02 octreotide
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase